Table 3.
Inpatient Management of Glycemic, Blood Pressure, and Lipid Parameters in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus
| Variables | 2021 (n=358) | 2022 (n=355) | 2023 (n=361) | χ2 | P |
|---|---|---|---|---|---|
| HbA1c<7.0% | 140 (39.11%) | 144(40.56%) | 187(51.80%) | 14.097 | <0.001 |
| ACS | 71 (34.63%) | 55(38.19%) | 56(29.95%) | 3.179 | 0.204 |
| CCS | 69 (45.10%)* | 89(61.81%) | 131(70.05%) | 27.368 | <0.001 |
| FBG<7.0 mmol/L | 202 (56.42%) | 221(62.25%) | 188(52.08%) | 7.605 | 0.022 |
| BP<130/80 mmHg | 92 (25.70%) | 110(30.99%) | 124(34.35%) | 6.463 | 0.039 |
| LDL-C<1.8 mmol/L | 147 (41.06%) | 146(41.13%) | 126(34.90%) | 3.861 | 0.145 |
| Three-goal achievers (HbA1c, BP, LDL-C) | 21 (5.86%) | 26(7.32%) | 22(6.09%) | 0.729 | 0.695 |
| Dual-goal achievers (HbA1c, LDL-C) | 69 (19.27%) | 79(22.25%) | 75(20.78%) | 0.962 | 0.618 |
| Dual-goal achievers (HbA1c, BP) | 35 (9.78%) | 41(11.55%) | 53(14.68%) | 4.199 | 0.123 |
| No-goal achievers | 106 (29.61%) | 101(28.45%) | 87(24.10%) | 3.053 | 0.217 |
Notes: *: p<0.05 (CCS vs ACS).